DK2861223T3 - Sammensætninger og metoder til transmukosal absorption - Google Patents
Sammensætninger og metoder til transmukosal absorption Download PDFInfo
- Publication number
- DK2861223T3 DK2861223T3 DK13804115.7T DK13804115T DK2861223T3 DK 2861223 T3 DK2861223 T3 DK 2861223T3 DK 13804115 T DK13804115 T DK 13804115T DK 2861223 T3 DK2861223 T3 DK 2861223T3
- Authority
- DK
- Denmark
- Prior art keywords
- compositions
- methods
- transmucosal absorption
- transmucosal
- absorption
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261660593P | 2012-06-15 | 2012-06-15 | |
US201261667774P | 2012-07-03 | 2012-07-03 | |
US201261725402P | 2012-11-12 | 2012-11-12 | |
US201361792900P | 2013-03-15 | 2013-03-15 | |
PCT/US2013/046023 WO2013188847A1 (en) | 2012-06-15 | 2013-06-14 | Compositions and methods for transmucosal absorption |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2861223T3 true DK2861223T3 (da) | 2022-11-07 |
Family
ID=49758769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13804115.7T DK2861223T3 (da) | 2012-06-15 | 2013-06-14 | Sammensætninger og metoder til transmukosal absorption |
Country Status (26)
Country | Link |
---|---|
US (1) | US20140171515A1 (da) |
EP (1) | EP2861223B1 (da) |
JP (5) | JP6259452B2 (da) |
CN (2) | CN104684550A (da) |
AR (1) | AR092330A1 (da) |
AU (2) | AU2013274003B2 (da) |
BR (1) | BR112014031394B1 (da) |
CA (2) | CA2876902C (da) |
DK (1) | DK2861223T3 (da) |
ES (1) | ES2929133T3 (da) |
HK (1) | HK1209361A1 (da) |
HR (1) | HRP20221325T1 (da) |
HU (1) | HUE060175T2 (da) |
IL (1) | IL236268B (da) |
LT (1) | LT2861223T (da) |
MX (2) | MX2014015436A (da) |
MY (1) | MY194495A (da) |
NZ (2) | NZ726488A (da) |
PL (1) | PL2861223T3 (da) |
PT (1) | PT2861223T (da) |
RS (1) | RS63822B1 (da) |
SG (2) | SG10201605407TA (da) |
SI (1) | SI2861223T1 (da) |
TW (3) | TWI683660B (da) |
WO (1) | WO2013188847A1 (da) |
ZA (1) | ZA201500288B (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2501234T (pt) | 2009-11-20 | 2017-12-13 | Tonix Pharma Holdings Ltd | Métodos e composições para o tratamento de sintomas associados com distúrbios de stress pós-traumático utilizando ciclobenzaprina |
US20110319389A1 (en) | 2010-06-24 | 2011-12-29 | Tonix Pharmaceuticals, Inc. | Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine |
US11998516B2 (en) | 2011-03-07 | 2024-06-04 | Tonix Pharma Holdings Limited | Methods and compositions for treating depression using cyclobenzaprine |
CA2904812C (en) | 2013-03-15 | 2021-07-20 | Tonix Pharmaceuticals, Inc. | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride |
CN107072968B (zh) * | 2014-09-18 | 2021-01-12 | 通尼克斯制药控股有限公司 | 环苯扎林盐酸盐的低共熔混合物配制剂 |
BR112018000707A2 (pt) * | 2015-07-15 | 2018-09-18 | Theranexus | ?composições terapêuticas e produto de combinação? |
WO2018045367A1 (en) * | 2016-09-02 | 2018-03-08 | Nova Southeastern University | Atropine sulfate rapidly-disintegrating sublingual tablets for treatment of acute organophosphate toxicity |
US11517557B2 (en) * | 2017-07-13 | 2022-12-06 | Tonix Pharmaceuticals Holding Corp. | Analogs of cyclobenzaprine and amitriptyline |
CN107519142B (zh) * | 2017-08-24 | 2021-02-26 | 正大制药(青岛)有限公司 | 一种盐酸环苯扎林舌下片及其制备方法 |
CN107496355B (zh) * | 2017-08-24 | 2021-04-30 | 正大制药(青岛)有限公司 | 一种盐酸环苯扎林舌下喷雾剂及其制备方法 |
AU2018379448A1 (en) * | 2017-12-08 | 2020-03-12 | F. Hoffmann-La Roche Ag | Pharmaceutical formulation |
AU2018383098A1 (en) | 2017-12-11 | 2020-05-28 | Tonix Pharma Holdings Limited | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions |
CN108721240A (zh) * | 2018-06-08 | 2018-11-02 | 华益药业科技(安徽)有限公司 | 一种25mg阿米替林薄膜包衣片处方和工艺规程 |
CA3109258A1 (en) | 2018-08-20 | 2020-02-27 | Tonix Pharma Holdings Limited | Methods of treating acute stress disorder and posttraumatic stress disorder |
CA3156118A1 (en) * | 2019-09-30 | 2021-04-08 | Cadila Healthcare Limited | INTRANASAL PHARMACEUTICAL COMPOSITIONS OF CYCLOBENZAPRINE |
CA3179754A1 (en) * | 2020-04-08 | 2021-10-14 | Tonix Pharmaceuticals Holding Corp. | Cyclobenzaprine treatment for sexual dysfunction |
WO2022109218A1 (en) | 2020-11-20 | 2022-05-27 | Tonix Pharmaceuticals Holding Corp. | Cyclobenzaprine treatment for alcohol use disorder |
CN116940340A (zh) | 2020-12-07 | 2023-10-24 | 通尼克斯医药控股公司 | 纤维肌痛的环苯扎林治疗 |
WO2022170107A2 (en) | 2021-02-04 | 2022-08-11 | Tonix Pharmaceuticals Holding Corp. | An improved method of assessing clinical response in the treatment of ptsd symptoms |
WO2023059728A1 (en) | 2021-10-06 | 2023-04-13 | Tonix Pharmaceuticals Holding Corp. | Cyclobenzaprine for treatment or prevention of sexual dysfunction associated with mental health conditions in female patients |
US20230414536A1 (en) | 2022-06-21 | 2023-12-28 | Tonix Pharmaceuticals Holding Corp. | CYCLOBENZAPRINE TREATMENT FOR POST-ACUTE SEQUELAE OF (SARS)-CoV-2 INFECTION (PASC) |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4968507A (en) * | 1984-06-20 | 1990-11-06 | Merck & Co., Inc. | Controlled porosity osmotic pump |
US20030077227A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
WO1999018937A1 (en) * | 1997-10-16 | 1999-04-22 | Merck & Co., Inc. | New cyclobenzaprine composition |
ATE229326T1 (de) * | 1998-05-14 | 2002-12-15 | Alza Corp | Therapie von depressionen |
AU6634000A (en) | 1999-08-13 | 2001-03-13 | Vela Pharmaceuticals Inc. | Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof |
ES2245944T3 (es) | 1999-08-13 | 2006-02-01 | Vela Pharmaceuticals Inc | Uso de composiciones para tratar o prevenir alteraciones del sueño utilizando dosis muy bajas de ciclobenzaprina. |
WO2001089476A1 (en) * | 2000-05-19 | 2001-11-29 | Npd Llc | Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements |
WO2002094229A1 (en) * | 2001-05-24 | 2002-11-28 | Alexza Molecular Delivery Corporation | Delivery of muscle relaxants through an inhalation route |
JP2006516963A (ja) * | 2003-02-04 | 2006-07-13 | クリサリス テクノロジーズ インコーポレイテッド | エアロゾル製剤及びブスピロン、ブプレノルフィン、トリアゾラム、シクロベンザプリン及びゾルピデムのエアロゾル送出 |
WO2006105205A1 (en) * | 2005-03-29 | 2006-10-05 | University Of Kentucky Research Foundation | Sublingual spray for the treatment of pain |
US20090148532A1 (en) * | 2007-12-06 | 2009-06-11 | Venkatesh Gopi M | Preparation of controlled release skeletal muscle relaxant dosage forms |
JP2009079060A (ja) * | 2008-10-15 | 2009-04-16 | Novadel Pharma Inc | 極性または非極性の、バッカルスプレーまたはカプセル |
US20100266682A1 (en) * | 2008-12-10 | 2010-10-21 | Nipun Davar | Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same |
US20100247586A1 (en) * | 2009-03-27 | 2010-09-30 | Andreas Hugerth | Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties |
PT2501234T (pt) * | 2009-11-20 | 2017-12-13 | Tonix Pharma Holdings Ltd | Métodos e composições para o tratamento de sintomas associados com distúrbios de stress pós-traumático utilizando ciclobenzaprina |
US20110319389A1 (en) * | 2010-06-24 | 2011-12-29 | Tonix Pharmaceuticals, Inc. | Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine |
ITMI20110558A1 (it) * | 2011-04-06 | 2012-10-07 | Campiglio Consulting Srl | Composizione farmaceutica contenente ciclobenzaprina adatta alla somministrazione endonasale |
CA2904812C (en) * | 2013-03-15 | 2021-07-20 | Tonix Pharmaceuticals, Inc. | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride |
-
2013
- 2013-06-14 MX MX2014015436A patent/MX2014015436A/es unknown
- 2013-06-14 TW TW107117266A patent/TWI683660B/zh active
- 2013-06-14 TW TW106117185A patent/TWI642429B/zh active
- 2013-06-14 HU HUE13804115A patent/HUE060175T2/hu unknown
- 2013-06-14 WO PCT/US2013/046023 patent/WO2013188847A1/en active Application Filing
- 2013-06-14 RS RS20221005A patent/RS63822B1/sr unknown
- 2013-06-14 AU AU2013274003A patent/AU2013274003B2/en active Active
- 2013-06-14 CN CN201380039522.6A patent/CN104684550A/zh active Pending
- 2013-06-14 AR ARP130102101A patent/AR092330A1/es not_active Application Discontinuation
- 2013-06-14 TW TW102121267A patent/TWI590820B/zh active
- 2013-06-14 NZ NZ726488A patent/NZ726488A/en unknown
- 2013-06-14 LT LTEPPCT/US2013/046023T patent/LT2861223T/lt unknown
- 2013-06-14 MY MYPI2014703784A patent/MY194495A/en unknown
- 2013-06-14 BR BR112014031394-6A patent/BR112014031394B1/pt active IP Right Grant
- 2013-06-14 CA CA2876902A patent/CA2876902C/en active Active
- 2013-06-14 HR HRP20221325TT patent/HRP20221325T1/hr unknown
- 2013-06-14 PL PL13804115.7T patent/PL2861223T3/pl unknown
- 2013-06-14 ES ES13804115T patent/ES2929133T3/es active Active
- 2013-06-14 PT PT138041157T patent/PT2861223T/pt unknown
- 2013-06-14 DK DK13804115.7T patent/DK2861223T3/da active
- 2013-06-14 NZ NZ631144A patent/NZ631144A/en unknown
- 2013-06-14 CN CN202010024102.2A patent/CN111388430A/zh active Pending
- 2013-06-14 CA CA3118913A patent/CA3118913C/en active Active
- 2013-06-14 US US13/918,692 patent/US20140171515A1/en active Pending
- 2013-06-14 SG SG10201605407TA patent/SG10201605407TA/en unknown
- 2013-06-14 SG SG11201408318RA patent/SG11201408318RA/en unknown
- 2013-06-14 SI SI201332010T patent/SI2861223T1/sl unknown
- 2013-06-14 MX MX2021005317A patent/MX2021005317A/es unknown
- 2013-06-14 JP JP2015517469A patent/JP6259452B2/ja active Active
- 2013-06-14 EP EP13804115.7A patent/EP2861223B1/en active Active
-
2014
- 2014-12-15 IL IL236268A patent/IL236268B/en unknown
-
2015
- 2015-01-15 ZA ZA2015/00288A patent/ZA201500288B/en unknown
- 2015-10-16 HK HK15110186.6A patent/HK1209361A1/xx unknown
-
2017
- 2017-10-02 JP JP2017192713A patent/JP2017222726A/ja not_active Withdrawn
-
2018
- 2018-10-04 AU AU2018241128A patent/AU2018241128B2/en active Active
-
2019
- 2019-05-14 JP JP2019091262A patent/JP2019123757A/ja not_active Withdrawn
-
2021
- 2021-06-16 JP JP2021100154A patent/JP2021138765A/ja not_active Withdrawn
-
2024
- 2024-02-02 JP JP2024014696A patent/JP2024032964A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2861223T3 (da) | Sammensætninger og metoder til transmukosal absorption | |
DK3421051T3 (da) | Fremgangsmåder til glycokonjugering og sammensætninger | |
DK2884999T3 (da) | Fremgangsmåde og sammensætninger til cellulær immunterapi | |
DK2929031T5 (da) | Pcsk9-irna-sammensætninger og fremgangsmåder til anvendelse deraf | |
DK2857401T3 (da) | Hidtil ukendt -lactamaseinhibitor og fremgangsmåde til at fremstille samme | |
DK2920167T3 (da) | Hydrazinyl-indol-forbindelser og konjugater | |
GB2499921B (en) | Biophotonic compositions, kits and methods | |
DK3578201T3 (da) | Fremgangsmåder og sammensætninger til naturlige dræberceller | |
DK2906684T3 (da) | T-celle-modificerende forbindelser og anvendelser deraf | |
BR112015003354A2 (pt) | composições e métodos de microcápsula | |
DK2850202T3 (da) | Fremgangsmåder og grupper | |
DK2872153T3 (da) | Accellulære pro-tolerogene sammensætninger og fremgangsmåde til fremstilling heraf | |
DK3550836T3 (da) | Fremgangsmåde og anordning til afkodning | |
BR112014032798A2 (pt) | composição | |
DK2928921T3 (da) | Sammensætninger og fremgangsmåder til antistoffer målrettet epo | |
DE102012104039A8 (de) | Hubtoranordnung sowie Torsturz-Abdichteinrichtung hierfür | |
DK3930322T3 (da) | Fremgangsmåder og anordninger til kodning | |
DK2917181T3 (da) | Heteroarylderivater og anvendelser deraf | |
DK2908661T3 (da) | Mikroalgemelgranulater og fremgangsmåde til fremstilling deraf | |
DK2830654T3 (da) | Metoder og sammensætninger til behandling af inflammation | |
DK2745849T3 (da) | Polydeoxyribonukleotidsammensætning og anvendelser deraf | |
DK2896694T3 (da) | Saccharidoxidase og fremgangsmåde til fremstilling deraf og anvendelse deraf | |
DK3175852T3 (da) | Difluorlactamsammensætninger til EP4-medierede osteorelaterede sygdomme og tilstande | |
DK2849798T3 (da) | Oligonukleotid-chelatkompleks-polypeptidsammensætninger og fremgangsmåder | |
DK2943460T3 (da) | 6-chlor-3-(phenyl-d5)-inden-1-on og anvendelse deraf |